{"code":1,"isDone":false,"toInsertArticleList":[{"createdTime":"2020-10-20 10:08:09","updatedTime":"2020-10-20 10:08:09","title":"高龄、基础病外的重症原因：干扰素缺失或致13%的新冠重症","link":"http://weixin.sogou.com/weixin?type=2&query=%E7%9F%A5%E8%AF%86%E5%88%86%E5%AD%90+%E9%AB%98%E9%BE%84%E3%80%81%E5%9F%BA%E7%A1%80%E7%97%85%E5%A4%96%E7%9A%84%E9%87%8D%E7%97%87%E5%8E%9F%E5%9B%A0%EF%BC%9A%E5%B9%B2%E6%89%B0%E7%B4%A0%E7%BC%BA%E5%A4%B1%E6%88%96%E8%87%B413%25%E7%9A%84%E6%96%B0%E5%86%A0%E9%87%8D%E7%97%87","description":"<div><div><div id=\"media\" class=\"rich_media_thumb_wrp\">\n\n            <img class=\"rich_media_thumb\" src=\"http://img.100weidu.com/mmbiz_jpg/LHibUTtMHPROeP328PJfB3Whv866whYyR2Gj9FXbN65R4k0QibULCBNUI2ZnpeCicz47gbXQvicprBE7OPnvNGrTJw?imageView2/1/w/600\">\n        </div>\n    \n\n    \n\n    <div class=\"rich_media_content\" id=\"js_content\">\n                    \n\n                    \n\n                    \n                    \n                    <section style=\"text-align: center;margin-left: 16px;margin-right: 16px;\"><img class=\"rich_pages js_insertlocalimg\" data-cropselx1=\"0\" data-cropselx2=\"546\" data-cropsely1=\"0\" data-cropsely2=\"364\" data-ratio=\"0.6661404893449092\" data-s=\"300,640\" data-type=\"png\" data-w=\"1267\" style=\"box-shadow: rgb(170, 170, 170) 0px 0px 14px 0px; width: 546px; height: 364px; max-width: 600px\" src=\"http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_png/LHibUTtMHPROeP328PJfB3Whv866whYyRLskFHqs4s9QSoKpNmGCTibuUd4dmFuGicprhMEicicbSg2BpmjazhjkalQ/640?wx_fmt=png\"></section><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;\"><span style=\"font-size: 16px;\"></span></section><p style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;text-align: right;line-height: 1.5em;\"><span style=\"color: rgb(123, 127, 131);font-size: 12px;\">图源：pixabay</span></p><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;\"><span style=\"font-size: 16px;\"> </span></section><p style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 2em;\"><strong><span style=\"font-size: 16px;\">撰文丨戴   威</span></strong></p><p style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 2em;\"><strong><span style=\"font-size: 16px;\">责编丨陈晓雪</span></strong><span style=\"font-size: 16px;\"></span></p><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;\"><span style=\"font-size: 16px;\"> </span></section><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;text-align: center;\"><span style=\"font-size: 16px;\"><span style=\"font-family: -apple-system-font, BlinkMacSystemFont, \" helvetica neue sc sans gb yahei ui arial sans-serif center rgb>●        </span><span style=\"font-family: -apple-system-font, BlinkMacSystemFont, \" helvetica neue sc sans gb yahei ui arial sans-serif center rgb>　</span><span style=\"font-family: -apple-system-font, BlinkMacSystemFont, \" helvetica neue sc sans gb yahei ui arial sans-serif center rgb>●        </span><span style=\"font-family: -apple-system-font, BlinkMacSystemFont, \" helvetica neue sc sans gb yahei ui arial sans-serif center rgb>　</span><span style=\"font-family: -apple-system-font, BlinkMacSystemFont, \" helvetica neue sc sans gb yahei ui arial sans-serif center rgb>●</span></span></section><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;text-align: center;\"><span style=\"font-size: 16px;\"><br></span></section><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;\"><span style=\"font-size: 16px;\">截至2020年10月18日，根据约翰·霍普金斯大学医学院的追踪统计，全球新冠感染者超过3973万人</span><span style=\"color: rgb(123, 127, 131);font-size: 14px;\"> [1]</span><span style=\"font-size: 16px;\">。大多数患者将出现发热、干咳或者疲乏等并不致命的症状。英国一项研究甚至指出，新冠核酸阳性者中有76%是连咳嗽、发热、味觉丧失等症状都没有无症状感染者</span><span style=\"color: rgb(123, 127, 131);font-size: 14px;\"> [2]</span><span style=\"font-size: 16px;\">。然而，即便如此，如今有111万人因新冠病毒不幸离世，约占已知感染者的2.8%</span><span style=\"color: rgb(123, 127, 131);font-size: 14px;\"> [1]</span><span style=\"font-size: 16px;\">。</span></section><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;\"><span style=\"font-size: 16px;\"> </span></section><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;\"><span style=\"font-size: 16px;\">是什么原因造成了症状差异？哪些人的病情更易发生恶化？以往的流行病学研究发现，高龄、男性、基础疾病这三大因素或增加重症风险 </span><span style=\"color: rgb(123, 127, 131);font-size: 14px;\">[3]</span><span style=\"font-size: 16px;\">。不过，即使是这几类人群内部，症状也有轻重之分。显然，有更多因素影响了新冠病情的发展。</span></section><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;\"><span style=\"font-size: 16px;\"> </span></section><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;\"><span style=\"font-size: 16px;\">2020年9月24日，《科学》</span><span style=\"font-size: 16px;color: rgb(123, 127, 131);\">（<em>Science</em>）</span><span style=\"font-size: 16px;\">发表的两项研究指出，I型干扰素缺失或可解释13%的新冠重症 </span><span style=\"color: rgb(123, 127, 131);font-size: 14px;\">[4,5]</span><span style=\"font-size: 16px;\">。这两项研究由同一个国际团队完成，分别从异常的自身抗体、遗传缺陷这两个角度讨论了I型干扰素缺失的影响。</span></section><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;\"><span style=\"font-size: 16px;\"> </span></section><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;\"><span style=\"font-size: 16px;\">干扰素是一类在病毒感染早期能唤起免疫响应的蛋白质，因其“干扰”病毒复制的能力而得名。对于已被病毒入侵的细胞，干扰素往往无济于事，因此它常作为疾病早期阶段抑制病情进展的一种疗法。</span></section><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;\"><span style=\"font-size: 16px;\"> </span></section><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;\"><span style=\"font-size: 16px;\">根据分泌来源、功能、结构等不同，干扰素又能分成许多型，大类有三个：I型、II型、III型。其中，I型干扰素种类最多，全身细胞皆可分泌，临床上能用来治疗病毒性肝炎和多发性硬化症等疾病。本次两篇研究讨论的都是I型干扰素。</span></section><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;\"><span style=\"font-size: 16px;\"> </span></section><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;\"><span style=\"font-size: 16px;\">I型干扰素走在身体对抗病毒入侵的前线。此前，有少量研究指出新冠重症或源于病毒让干扰素失效 </span><span style=\"color: rgb(123, 127, 131);font-size: 14px;\">[6]</span><span style=\"font-size: 16px;\">。至于为什么 “失效”，还缺乏更多解释。</span></section><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;\"><span style=\"font-size: 16px;\"> </span></section><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;\"><span style=\"font-size: 16px;\">本次《科学》刊发的两项研究，临床样本来自世界各地，观察了重症患者与轻症患者或无症状感染者有何不同。研究发现，</span><strong><span style=\"font-size: 16px;color: rgb(65, 70, 75);\">10.2%的重症患者体内有攻击干扰素的异常抗体；3.5%的重症患者存在让I型干扰素无法正常发挥功能的基因变异，而两项研究中轻症或无症状人群里皆未发现异常。也就是说，干扰素缺失或许可以解释13.7%的新冠重症。</span></strong></section><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;\"><span style=\"font-size: 16px;\"> </span></section><section data-role=\"outer\" label=\"Powered by 135editor.com\"><section data-tools=\"135编辑器\" data-id=\"98857\"><section><section style=\"margin: 10px auto;text-align: center;\" hm_fix=\"213:270\"><section style=\"display: inline-block;padding-top: 2em;padding-bottom: 10px;padding-left: 20px;\"><section style=\"margin-bottom:-35px;margin-left:-20px;transform: rotate(25deg);-webkit-transform: rotate(25deg);-moz-transform: rotate(25deg);-ms-transform: rotate(25deg);-o-transform: rotate(25deg);\"><section style=\"background-color: rgb(255, 255, 255);padding-top: 8px;padding-bottom: 8px;width: 130px;height: 16px;overflow: hidden;\"><br></section></section><section style=\"padding: 6px;border-width: 1px;border-style: solid;border-color: rgb(119, 137, 232);border-radius: 100%;display: inline-block;\"><section style=\"width: 50px;height: 50px;background: rgb(185, 194, 243);border-radius: 100%;overflow: hidden;transform: rotate(0deg);-webkit-transform: rotate(0deg);-moz-transform: rotate(0deg);-ms-transform: rotate(0deg);-o-transform: rotate(0deg);\"><br></section></section><section style=\"font-size: 60px;margin-top: -90px;font-weight: bold;color:#3e44e1;text-shadow:3px 4px #98a3e8;transform: rotate(0deg) skew(-8deg);-webkit-transform: rotate(0deg) skew(-8deg);-moz-transform: rotate(0deg) skew(-8deg);-ms-transform: rotate(0deg) skew(-8deg);-o-transform: rotate(0deg) skew(-8deg);\" data-original-title=\"\" title=\"\">1</section></section></section></section></section></section><p style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;text-align: center;line-height: 1.5em;\"><span style=\"color: rgb(55, 103, 210);\"><strong><span style=\"color: rgb(55, 103, 210);font-size: 16px;\">异常抗体 “自家人打自家人”</span></strong></span></p><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;\"><span style=\"font-size: 16px;\"> </span></section><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;\"><span style=\"font-size: 16px;\">干扰素是个好东西，但我们的免疫系统中出现的</span><span style=\"font-size: 16px;\">自身抗体</span><span style=\"font-size: 16px;color: rgb(123, 127, 131);\">（autoantibody）</span><span style=\"font-size: 16px;\">，会让身体 “残杀” 干扰素。</span></section><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;\"><span style=\"font-size: 16px;\"> </span></section><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;\"><span style=\"font-size: 16px;\">抗体是免疫系统的武器，通常它们的对手是入侵身体的特定细菌、病毒等抗原。不过，有些抗体会针对自身的组织、细胞等开火—— 它们称为“自身抗体”，如果数量太多就会损伤机体。不幸的是，我们的人体内，也存在攻击I型干扰素的自身抗体。</span></section><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;\"><span style=\"font-size: 16px;\"> </span></section><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;\"><span style=\"font-size: 16px;\">在这两篇《科学》论文中，其中的一篇</span><span style=\"color: rgb(123, 127, 131);font-size: 14px;\"> [4]</span><span style=\"font-size: 16px;\">，我们姑且称之为论文A，涉及到987名新冠重症患者，663名轻症患者或无症状感染者。研究发现，10.2%</span><span style=\"font-size: 16px;color: rgb(123, 127, 131);\">（101）</span><span style=\"font-size: 16px;\">的重症患者体内有攻击I型干扰素的自身抗体。而轻症或无症状组中无一人出现这种自身抗体。</span></section><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;\"><span style=\"font-size: 16px;\"> </span></section><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;\"><span style=\"font-size: 16px;\">研究中，所有重症患者的血样取自急症期。在体内存在自身抗体的重症患者中，I型干扰素水平极低甚至测不出来。实验室研究发现，在这些重症患者的血浆之中，本能分泌干扰素的细胞失去了抵挡新冠病毒的能力——这些异常的抗体让I型干扰素失效了 </span><span style=\"color: rgb(123, 127, 131);font-size: 14px;\">[7]</span><span style=\"font-size: 16px;\">。</span></section><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;\"><span style=\"font-size: 16px;\"> </span></section><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;\"><span style=\"font-size: 16px;\">论文A还检查了1227个新冠疫情前采集的健康人样本，其中发现4例</span><span style=\"font-size: 16px;color: rgb(123, 127, 131);\">（0.33%）</span><span style=\"font-size: 16px;\">有自身抗体。</span></section><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;\"><span style=\"font-size: 16px;\"> </span></section><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;\"><span style=\"font-size: 16px;\">自身抗体存在率10.2%与0，是重症人群和其他感染者的显著区别。显然，自身抗体与新冠病情发展是相关的，那么，是病重导致人体内自身抗体大增，还是有自身抗体的人容易病重呢？</span></section><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;\"><span style=\"font-size: 16px;\"> </span></section><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;\"><span style=\"font-size: 16px;\">研究人员认为，<strong>是先有抗体后有病情</strong>，这里有很强的因果性</span><span style=\"font-size: 16px;color: rgb(123, 127, 131);\">（a strong case for causality）</span><span style=\"font-size: 16px;\">。原因有两个，首先，自身抗体在新冠疫情前已经存在于人群了</span><span style=\"font-size: 16px;color: rgb(123, 127, 131);\">（0.33%）</span><span style=\"font-size: 16px;\">，并不是新冠带来的新东西。第二，如果这种自身抗体是感染后出现的免疫响应产物，那么不太可能在短时间内分泌到如此高的水平</span><span style=\"color: rgb(123, 127, 131);font-size: 14px;\"> [7]</span><span style=\"font-size: 16px;\">。</span></section><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;\"><span style=\"font-size: 16px;\"> </span></section><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;\"><span style=\"font-size: 16px;\">值得注意的是，101名携带自身抗体的重症患者中男性占95人</span><span style=\"font-size: 16px;color: rgb(123, 127, 131);\">（94%）</span><span style=\"font-size: 16px;\">。而通常，患有自身免疫疾病的人更多为女性。研究作者之一、洛克菲勒大学传染病遗传学家让-劳伦·卡萨诺瓦</span><span style=\"font-size: 16px;color: rgb(123, 127, 131);\">（Jean-Laurent Casanova）</span><span style=\"font-size: 16px;\">推测，<strong>这种自身抗体之所以在女性中少见，可能因其来自X染色体相关的隐性性状。</strong></span></section><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;\"><span style=\"font-size: 16px;\"> </span></section><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;\"><span style=\"font-size: 16px;\">由于女性有两条X染色体，想要表达隐性性状，必须有两个携带隐性基因的染色体碰到一起。如果一个是隐性，另一个是显性，那么这个糟糕的性状就不会表达。而男性只有一条X染色体，是隐性基因就表达隐性性状，没有被另一条携带显性基因的染色体“搭救”的机会。</span></section><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;\"><span style=\"font-size: 16px;\"> </span></section><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;\"><span style=\"font-size: 16px;\">“女性有两条X染色体，是被保护的。而男性只有一条，因此不被保护。” 卡萨诺瓦解释道。一个支持这个猜想的证据是，一位携带自身抗体的新冠重症女性正好患有罕见病症—— 单个X染色体沉默。</span><span style=\"color: rgb(123, 127, 131);font-size: 14px;\">[7]</span></section><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;\"><span style=\"font-size: 16px;\"> </span></section><section data-role=\"outer\" label=\"Powered by 135editor.com\"><section data-tools=\"135编辑器\" data-id=\"98857\"><section><section style=\"margin: 10px auto;text-align: center;\" hm_fix=\"213:270\"><section style=\"display: inline-block;padding-top: 2em;padding-bottom: 10px;padding-left: 20px;\"><section style=\"margin-bottom:-35px;margin-left:-20px;transform: rotate(25deg);-webkit-transform: rotate(25deg);-moz-transform: rotate(25deg);-ms-transform: rotate(25deg);-o-transform: rotate(25deg);\"><section style=\"background-color: rgb(255, 255, 255);padding-top: 8px;padding-bottom: 8px;width: 130px;height: 16px;overflow: hidden;\"><br></section></section><section style=\"padding: 6px;border-width: 1px;border-style: solid;border-color: rgb(119, 137, 232);border-radius: 100%;display: inline-block;\"><section style=\"width: 50px;height: 50px;background: rgb(185, 194, 243);border-radius: 100%;overflow: hidden;transform: rotate(0deg);-webkit-transform: rotate(0deg);-moz-transform: rotate(0deg);-ms-transform: rotate(0deg);-o-transform: rotate(0deg);\"><br></section></section><section style=\"font-size: 60px;margin-top: -90px;font-weight: bold;color:#3e44e1;text-shadow:3px 4px #98a3e8;transform: rotate(0deg) skew(-8deg);-webkit-transform: rotate(0deg) skew(-8deg);-moz-transform: rotate(0deg) skew(-8deg);-ms-transform: rotate(0deg) skew(-8deg);-o-transform: rotate(0deg) skew(-8deg);\" data-original-title=\"\" title=\"\">2</section></section></section></section></section></section><p style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;text-align: center;line-height: 1.5em;\"><span style=\"color: rgb(55, 103, 210);\"><strong><span style=\"color: rgb(55, 103, 210);font-size: 16px;\">遗传缺陷致I型干扰素失效</span></strong></span></p><p style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.5em;\"><span style=\"font-size: 16px;\"> </span></p><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;\"><span style=\"font-size: 16px;\">除了攻击自己的异常抗体，遗传缺陷也会影响I型干扰素的功能。此前，已知一些基因位点的功能缺失会影响I型干扰素的产生和信号传递，最终造成流感肺炎易感。那么，这些基因位置的变异也会加重新冠肺炎重症风险吗？</span></section><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;\"><span style=\"font-size: 16px;\"> </span></section><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;\"><span style=\"font-size: 16px;\">另一篇研究，不妨称之为论文B，顺着这个思路找目标—— 从那些能导致重症流感肺炎的I型干扰素缺陷相关的基因变异下手</span><span style=\"color: rgb(123, 127, 131);font-size: 14px;\"> [5]</span><span style=\"font-size: 16px;\">。</span></section><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;\"><span style=\"font-size: 16px;\"> </span></section><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;\"><span style=\"font-size: 16px;\">要检查的基因位置有13个，它们与 TLR3-和IRF7-依赖性I型干扰素先天缺陷相关。其中3个位置在重症流感肺炎患者体内出现变异；另外10处的变异出现在其他病毒性疾病患者身上，但与导致流感易感性的3处核心基因直接相关联。</span></section><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;\"><span style=\"font-size: 16px;\"> </span></section><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;\"><span style=\"font-size: 16px;\">研究者想看看新冠重症患者中，这些基因位点是否也有变异。如有，那么他们的I型干扰素也是不能正常发挥功能的。</span></section><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;\"><span style=\"font-size: 16px;\"> </span></section><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;\"><span style=\"font-size: 16px;\">论文B涉及659名新冠重症患者的样本。同时有534名轻症或无症状新冠感染者作为对照组。</span></section><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;\"><span style=\"font-size: 16px;\"> </span></section><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;\"><span style=\"font-size: 16px;\">最终，研究者在23名重症患者</span><span style=\"font-size: 16px;color: rgb(123, 127, 131);\">（3.5%）</span><span style=\"font-size: 16px;\">身上找到先天性变异，涉及8个位置。他们来自亚洲、欧洲、拉美、中东在内的世界各地，年龄在17至77之间，有男有女。在能获得的这些患者的血样中，I型干扰素水平低到趋近于无。</span></section><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;\"><span style=\"font-size: 16px;\"> </span></section><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;\"><span style=\"font-size: 16px;\">与之相对，534人轻症或无症状患者的对照组里13个基因位置无一异常。研究者指出，<strong>与I型干扰素相关的先天免疫缺陷可能导致严重的新冠肺炎。</strong></span></section><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;\"><span style=\"font-size: 16px;\"> </span></section><section data-role=\"outer\" label=\"Powered by 135editor.com\"><section data-tools=\"135编辑器\" data-id=\"98857\"><section><section style=\"margin: 10px auto;text-align: center;\" hm_fix=\"213:270\"><section style=\"display: inline-block;padding-top: 2em;padding-bottom: 10px;padding-left: 20px;\"><section style=\"margin-bottom:-35px;margin-left:-20px;transform: rotate(25deg);-webkit-transform: rotate(25deg);-moz-transform: rotate(25deg);-ms-transform: rotate(25deg);-o-transform: rotate(25deg);\"><section style=\"background-color: rgb(255, 255, 255);padding-top: 8px;padding-bottom: 8px;width: 130px;height: 16px;overflow: hidden;\"><br></section></section><section style=\"padding: 6px;border-width: 1px;border-style: solid;border-color: rgb(119, 137, 232);border-radius: 100%;display: inline-block;\"><section style=\"width: 50px;height: 50px;background: rgb(185, 194, 243);border-radius: 100%;overflow: hidden;transform: rotate(0deg);-webkit-transform: rotate(0deg);-moz-transform: rotate(0deg);-ms-transform: rotate(0deg);-o-transform: rotate(0deg);\"><br></section></section><section style=\"font-size: 60px;margin-top: -90px;font-weight: bold;color:#3e44e1;text-shadow:3px 4px #98a3e8;transform: rotate(0deg) skew(-8deg);-webkit-transform: rotate(0deg) skew(-8deg);-moz-transform: rotate(0deg) skew(-8deg);-ms-transform: rotate(0deg) skew(-8deg);-o-transform: rotate(0deg) skew(-8deg);\" data-original-title=\"\" title=\"\">3</section></section></section></section></section></section><p style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;text-align: center;line-height: 1.5em;\"><span style=\"color: rgb(55, 103, 210);\"><strong><span style=\"color: rgb(55, 103, 210);font-size: 16px;\">重症原因冰山一角，患者或需特殊治疗</span></strong></span></p><p style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.5em;\"><span style=\"font-size: 16px;\"> </span></p><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;\"><span style=\"font-size: 16px;\">哈德逊医学研究中心的干扰素专家保罗·赫佐格</span><span style=\"font-size: 16px;color: rgb(123, 127, 131);\">（Paul Hertzog）</span><span style=\"font-size: 16px;\">认为，在揭示新冠病情发展的原因上，这两项研究“可能只是冰山的一角”[7]。许多干扰素相关或不相关的变异，也许都在病情中扮演了某种角色。</span></section><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;\"><span style=\"font-size: 16px;\"> </span></section><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;\"><span style=\"font-size: 16px;\">研究团队在论文B中指出，导致新冠重症的可能还有其他与I型干扰素相关的基因。</span></section><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;\"><span style=\"font-size: 16px;\"> </span></section><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;\"><span style=\"font-size: 16px;\">这两项研究有很强的的实践指导意义。对于新冠治疗，研究者指出，如果使用血浆疗法，携带干扰素自身抗体的新冠感染者康复后不能作为血浆捐献人</span><span style=\"color: rgb(123, 127, 131);font-size: 14px;\"> [4]</span><span style=\"font-size: 16px;\">。</span></section><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;\"><span style=\"font-size: 16px;\"> </span></section><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;\"><span style=\"font-size: 16px;\">而对于I型干扰素缺失的人群，可能需要特别的干预治疗，例如用血浆除去法 “洗” 掉自身抗体等</span><span style=\"color: rgb(123, 127, 131);font-size: 14px;\"> [4]</span><span style=\"font-size: 16px;\">。</span></section><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;\"><span style=\"font-size: 16px;\"> </span></section><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;\"><span style=\"font-size: 16px;\">未雨绸缪也是一种方案。“可以快速开发一种常见的抗体检测，能几小时内出检测结果。那些具有高风险发展成新冠重症的人可以优先打疫苗或者避免暴露。” 加州大学圣迭戈分校的免疫学家伊琳娜·苏尼卡</span><span style=\"font-size: 16px;color: rgb(123, 127, 131);\">（Elina Zuniga）</span><span style=\"font-size: 16px;\">如是建议 </span><span style=\"color: rgb(123, 127, 131);font-size: 14px;\">[7]</span><span style=\"font-size: 16px;\">。按照本次研究的数据，每300人中就有一人携带针对I型干扰素的自身抗体</span><span style=\"font-size: 16px;color: rgb(123, 127, 131);\">（0.33%）</span><span style=\"font-size: 16px;\">。</span></section><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;\"><span style=\"font-size: 16px;\"> </span></section><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;\"><span style=\"font-size: 16px;\">此次疫情中，干扰素治疗已在数十个临床试验中进行，不过，对于携带针对I型干扰素自身抗体或者I型干扰素有先天功能缺陷的患者，合成干扰素可能效果不大</span><span style=\"color: rgb(123, 127, 131);font-size: 14px;\"> [7]</span><span style=\"font-size: 16px;\">。研究团队指出，携带自身抗体的患者也许可以在治疗早期尝试注射或吸入I型干扰素中的β型</span><span style=\"font-size: 16px;color: rgb(123, 127, 131);\">（</span><span style=\"font-size: 16px;color: rgb(123, 127, 131);\">INF-β</span><span style=\"font-size: 16px;color: rgb(123, 127, 131);\">）</span><span style=\"font-size: 16px;\">，因为这些患者体内的自身抗体很少针对β型，而I型干扰素的α型</span><span style=\"font-size: 16px;color: rgb(123, 127, 131);\">（INF-α）</span><span style=\"font-size: 16px;\">就不太可能有用了</span><span style=\"color: rgb(123, 127, 131);font-size: 14px;\"> [4]</span><span style=\"font-size: 16px;\">。</span></section><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;\"><span style=\"font-size: 16px;\"> </span></section><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;\"><span style=\"font-size: 16px;\">目前，唯一一种被证明对新冠重症有效的药物是地塞米松。这种糖皮质类激素具有抗炎症和免疫抑制作用，能降低新冠重症患者的死亡率 </span><span style=\"color: rgb(123, 127, 131);font-size: 14px;\">[8]</span><span style=\"font-size: 16px;\">。</span></section><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;\"><span style=\"font-size: 16px;\"> </span></section><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;\"><span style=\"font-size: 16px;\">10月5日《柳叶刀》一篇研究评述认为，包括β干扰素、单克隆抗体、抗病毒药物在内的这些抑制病毒复制的疗法，在病情早期或轻症患者身上是有用的。但对于重症患者光抗病毒不够，抗病毒药物和免疫调节剂联合治疗或许是医治新冠重症的方向 </span><span style=\"color: rgb(123, 127, 131);font-size: 14px;\">[9]</span><span style=\"font-size: 16px;\">。</span><img class=\"rich_pages\" data-ratio=\"0.9782608695652174\" data-s=\"300,640\" data-type=\"png\" data-w=\"92\" style=\"font-family: -apple-system-font, BlinkMacSystemFont,; max-width: 600px\" helvetica neue sc sans gb yahei ui arial sans-serif normal rgb border-box visible src=\"http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_png/LHibUTtMHPRM5Ud8d7rOrOJZmevzXI7jkWPQBKNS1T4U2CFbBsLHLZqKukUV52RiaDRiaVKuLnOshZeeEDWuDse3w/640?wx_fmt=png\"><span style=\"font-family: -apple-system-font, BlinkMacSystemFont, \" helvetica neue sc sans gb yahei ui arial sans-serif rgb> </span><section data-role=\"paragraph\" style=\"letter-spacing: 0.544px;font-family: -apple-system-font, BlinkMacSystemFont, Arial, sans-serif;\"><section style=\"letter-spacing: 0.544px;\"><section style=\"margin-right: 8px;margin-left: 8px;text-align: left;width: 677px;line-height: 1.75em;\"><section style=\"display: inline-block;width: 677px;height: 240px;vertical-align: top;overflow-y: auto;\"><section style=\"overflow-x: hidden;\"><section powered-by=\"135编辑器\" style=\"margin-top: 20px;\"><section style=\"padding: 0.1em 0.3em;display: inline-block;border-width: 2px;border-style: solid;border-color: rgb(252, 251, 251);\"><section data-role=\"outer\"><section data-role=\"paragraph\"><p style=\"margin-right: 16px;margin-left: 16px;color: rgb(62, 62, 62);font-size: 16px;letter-spacing: 1px;line-height: 1.5em;\"><strong style=\"color: rgb(123, 127, 131);font-size: 14px;font-family: -apple-system-font, BlinkMacSystemFont, \" helvetica neue sc sans gb yahei ui arial sans-serif><span style=\"letter-spacing: 1px;color: rgb(136, 136, 136);\"><img class=\"rich_pages __bg_gif\" data-ratio=\"1\" data-type=\"gif\" data-w=\"200\" style=\"text-align: center; box-sizing: border-box !important; visibility: visible !important; width: 20px !important; max-width: 600px\" src=\"http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_gif/LHibUTtMHPRM5Ud8d7rOrOJZmevzXI7jkbtS6NgcCtYfhOYnbRDqWPyibaelA4pIB0lvdg99hJfsmdibm2Eibg6dDQ/640?wx_fmt=gif\"> 参考资料</span></strong></p><section style=\"margin-right: 16px;margin-left: 16px;white-space: normal;text-align: left;letter-spacing: 1px;line-height: 1.5em;\"><span style=\"color: rgb(123, 127, 131);font-size: 14px;\">[1] COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University. https://coronavirus.jhu.edu/map.html</span></section><section style=\"margin-right: 16px;margin-left: 16px;white-space: normal;text-align: left;letter-spacing: 1px;line-height: 1.5em;\"><span style=\"color: rgb(123, 127, 131);font-size: 14px;\">[2] Three Quarters of People with SARS-CoV-2 Infection are Asymptomatic: Analysis of English Household Survey Data</span></section><section style=\"margin-right: 16px;margin-left: 16px;white-space: normal;text-align: left;letter-spacing: 1px;line-height: 1.5em;\"><span style=\"color: rgb(123, 127, 131);font-size: 14px;\">https://www.dovepress.com/three-quarters-of-people-with-sars-cov-2-infection-are-asymptomatic-an-peer-reviewed-article-CLEP</span></section><section style=\"margin-right: 16px;margin-left: 16px;white-space: normal;text-align: left;letter-spacing: 1px;line-height: 1.5em;\"><span style=\"color: rgb(123, 127, 131);font-size: 14px;\">[3] D. M. Morens, A. S. Fauci, Emerging pandemic diseases: How we got to COVID-19. Cell, 182,  (2020):1077–1092.</span></section><section style=\"margin-right: 16px;margin-left: 16px;white-space: normal;text-align: left;letter-spacing: 1px;line-height: 1.5em;\"><span style=\"color: rgb(123, 127, 131);font-size: 14px;\">[4] Bastard et al.,”Auto-antibodies against type I IFNs in patients with life-threatening COVID-19.” Science, (2020): eabd4585</span></section><section style=\"margin-right: 16px;margin-left: 16px;white-space: normal;text-align: left;letter-spacing: 1px;line-height: 1.5em;\"><span style=\"color: rgb(123, 127, 131);font-size: 14px;\">[5] Zhang et al., “Inborn errors of type I IFN immunity in patients with life-threatening COVID-19.” Science, (2020): eabd4570</span></section><section style=\"margin-right: 16px;margin-left: 16px;white-space: normal;text-align: left;letter-spacing: 1px;line-height: 1.5em;\"><span style=\"color: rgb(123, 127, 131);font-size: 14px;\">[6] Can interferons stop COVID-19 before it takes hold? https://science.sciencemag.org/content/369/6500/125.full</span></section><section style=\"margin-right: 16px;margin-left: 16px;white-space: normal;text-align: left;letter-spacing: 1px;line-height: 1.5em;\"><span style=\"color: rgb(123, 127, 131);font-size: 14px;\">[7]Hidden immune weakness found in 14% of gravely ill COVID-19 patients. https://www.sciencemag.org/news/2020/09/hidden-immune-weakness-found-14-gravely-ill-covid-19-patients</span></section><section style=\"margin-right: 16px;margin-left: 16px;white-space: normal;text-align: left;letter-spacing: 1px;line-height: 1.5em;\"><span style=\"color: rgb(123, 127, 131);font-size: 14px;\">[8]The RECOVERY Collaborative Group. Dexamethasone in hospitalized patients with Covid-19—preliminary report. N Engl J Med 2020; published online July 17. https://doi.org/10.1056/NEJMoa2021436.</span></section><section style=\"margin-right: 16px;margin-left: 16px;white-space: normal;text-align: left;letter-spacing: 1px;line-height: 1.5em;\"><span style=\"color: rgb(123, 127, 131);font-size: 14px;\">[9] 呼吸界. 曹彬、Frederick G Hayden教授在《柳叶刀》发表述评：抗病毒单药不足以治疗COVID-19住院患者. https://mp.weixin.qq.com/s/86Wlg2TpdkMdoZHZ2X5JZw</span></section></section></section></section></section></section></section></section></section></section></section><section style=\"margin-right: 16px;margin-left: 16px;font-family: -apple-system-font, BlinkMacSystemFont, \" helvetica neue sc sans gb yahei ui arial sans-serif normal right><br></section><section style=\"margin-left: 16px;margin-right: 16px;letter-spacing: 1.5px;line-height: 1.75em;\"><span style=\"font-size: 16px;\"></span></section><section powered-by=\"135编辑器\" style=\"font-family: -apple-system-font, BlinkMacSystemFont, \" helvetica neue sc sans gb yahei ui arial sans-serif normal rgb><p style=\"margin-right: 16px;margin-left: 16px;text-align: right;letter-spacing: 1px;line-height: normal;\"><span style=\"color: rgb(123, 127, 131);font-size: 14px;\"> </span><span style=\"font-size: 14px;color: rgb(136, 136, 136);letter-spacing: 0.54px;font-family: -apple-system-font, BlinkMacSystemFont, Arial, sans-serif;\">制版编辑 </span><span style=\"font-size: 14px;color: rgb(255, 76, 0);letter-spacing: 0.54px;font-family: -apple-system-font, BlinkMacSystemFont, Arial, sans-serif;\">| </span><span style=\"font-size: 14px;color: rgb(136, 136, 136);letter-spacing: 0.54px;font-family: -apple-system-font, BlinkMacSystemFont, Arial, sans-serif;\">卢卡斯</span><br></p></section><section style=\"margin-right: 16px;margin-left: 16px;font-family: -apple-system-font, BlinkMacSystemFont, \" helvetica neue sc sans gb yahei ui arial sans-serif normal right rgb><br></section><section label=\"Powered by 135editor.com\" data-role=\"outer\" style=\"font-family: -apple-system-font, BlinkMacSystemFont, \" helvetica neue sc sans gb yahei ui arial sans-serif normal rgb><section data-role=\"paragraph\"><section data-role=\"paragraph\"><section data-id=\"95447\" data-width=\"96%\" data-tools=\"135编辑器\" style=\"margin-right: auto;margin-left: auto;width: 649.9px;\"><section data-width=\"100%\" style=\"margin: 1em auto;width: 649.9px;\"><section data-autoskip=\"1\" style=\"margin-top: -10px;padding: 1em;border-width: 1px;border-style: solid;border-color: rgb(255, 255, 255);color: rgb(255, 255, 255);line-height: 1.75em;letter-spacing: 1.5px;font-size: 14px;\"><section style=\"margin-right: 16px;margin-left: 16px;\"><br></section><section data-role=\"paragraph\"><section style=\"margin-right: 16px;margin-left: 16px;text-align: center;\"><img border=\"0\" class=\"__bg_gif\" data-ratio=\"0.08658008658008658\" data-type=\"gif\" data-w=\"462\" data-width=\"80%\" height=\"\" title=\"\" width=\"80%\" style=\"letter-spacing: 0.54px; box-sizing: border-box !important; visibility: visible !important; width: 470.31px !important; max-width: 600px\" src=\"http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_gif/lBLXrFcccXFwZwrMI7x3Idm0WicwB4ibviaNqA7dU3PEVQZrafvvMVQV4muo1DuHlPLtLIAwFbMWic5VGyn7G1vIuQ/640?wx_fmt=gif\"></section></section></section></section></section></section></section></section><section style=\"margin-right: 16px;margin-left: 16px;font-family: -apple-system-font, BlinkMacSystemFont, \" helvetica neue sc sans gb yahei ui arial sans-serif normal center rgb><a target=\"_blank\" href=\"http://mp.weixin.qq.com/s?__biz=MzIyNDA2NTI4Mg==&amp;mid=2655453309&amp;idx=2&amp;sn=59baf0ad075bd0f6f8a8027430709660&amp;chksm=f3a70210c4d08b069b8669c1ffce9770c5ce5bbb7cd6c5a45aecd526fb9241508ddbfc8fd52d&amp;scene=21#wechat_redirect\" textvalue=\"你已选中了添加链接的内容\" data-itemshowtype=\"11\" tab=\"innerlink\" data-linktype=\"1\"><span class=\"js_jump_icon h5_image_link\" data-positionback=\"static\" style=\"top: auto;left: auto;margin: 0px;right: auto;bottom: auto;\"><img class=\"rich_pages\" data-cropselx1=\"0\" data-cropselx2=\"520\" data-cropsely1=\"0\" data-cropsely2=\"131\" data-ratio=\"0.2520833333333333\" data-s=\"300,640\" data-type=\"jpeg\" data-w=\"960\" style=\"border-width: 0px; border-style: initial; border-color: initial; border-radius: 12px; left: auto; top: auto; right: auto; bottom: auto; box-sizing: border-box !important; visibility: visible !important; width: 520px; height: 131px; margin: 0px; max-width: 600px\" src=\"http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_jpg/LHibUTtMHPROeP328PJfB3Whv866whYyRZeZm1ibBIlJCS7PDbZHtjSuA5ZNtZlGLE4B7XocR1GzDf7HXxHQl7UQ/640?wx_fmt=jpeg\"></span></a></section><section style=\"margin-right: 16px;margin-left: 16px;font-family: -apple-system-font, BlinkMacSystemFont, \" helvetica neue sc sans gb yahei ui arial sans-serif normal center rgb><a target=\"_blank\" href=\"http://mp.weixin.qq.com/s?__biz=MzIyNDA2NTI4Mg==&amp;mid=2655442407&amp;idx=2&amp;sn=ce5d1aa897fd8ae53fcabae7f22e29fe&amp;chksm=f3a6d78ac4d15e9c277fc556b1340004247f5f9d83a2e48530d31fe8bc957660a8ff89955626&amp;scene=21#wechat_redirect\" textvalue=\"你已选中了添加链接的内容\" data-itemshowtype=\"0\" tab=\"innerlink\" data-linktype=\"2\" hasload=\"1\" style=\"-webkit-tap-highlight-color: rgba(0, 0, 0, 0);cursor: pointer;font-size: 14px;letter-spacing: 0.54px;\"></a><a target=\"_blank\" href=\"http://mp.weixin.qq.com/s?__biz=MzIyNDA2NTI4Mg==&amp;mid=2655451945&amp;idx=2&amp;sn=4f32cdd847f15e81ca2994f07d6cf7e5&amp;chksm=f3a6f944c4d17052f30fbb3951cdcec7ec6648056e23c0b0e2c5711e2f359bd824794dd3976b&amp;scene=21#wechat_redirect\" textvalue=\"你已选中了添加链接的内容\" data-itemshowtype=\"0\" tab=\"innerlink\" data-linktype=\"1\" hasload=\"1\" style=\"color: var(--weui-LINK);-webkit-tap-highlight-color: rgba(0, 0, 0, 0);cursor: pointer;font-family: -apple-system-font, BlinkMacSystemFont, \" helvetica neue sc sans gb yahei ui arial sans-serif center normal rgb><span class=\"js_jump_icon h5_image_link\" data-positionback=\"static\" style=\"line-height: 0;top: auto;left: auto;right: auto;bottom: auto;\"><img class=\"rich_pages\" data-cropselx1=\"0\" data-cropselx2=\"520\" data-cropsely1=\"0\" data-cropsely2=\"131\" data-ratio=\"0.252\" data-s=\"300,640\" data-type=\"jpeg\" data-w=\"1000\" style=\"border-width: 0px; border-style: initial; border-color: initial; border-radius: 12px; left: auto; top: auto; right: auto; bottom: auto; box-sizing: border-box !important; visibility: visible !important; width: 520px !important; max-width: 600px\" src=\"http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_jpg/LHibUTtMHPRMDggld9qfmopYm6Ss6b1VH3uXvwVQaZ2TQZO7RSa42BTTxzGXrs4xricISG9qH0TZZpXS4xWgtiagQ/640?wx_fmt=jpeg\"></span></a><br></section><section style=\"margin-right: 16px;margin-left: 16px;font-family: -apple-system-font, BlinkMacSystemFont, \" helvetica neue sc sans gb yahei ui arial sans-serif normal center rgb><a target=\"_blank\" href=\"http://mp.weixin.qq.com/s?__biz=MzIyNDA2NTI4Mg==&amp;mid=2655448372&amp;idx=3&amp;sn=bc8ab21e70cd89d0251e7057ea1f0712&amp;chksm=f3a6ef59c4d1664fb7f5600d4f0e72dd0f113b1d5283eaba74c1544ec214a8aba579ebdd6be6&amp;scene=21#wechat_redirect\" textvalue=\"你已选中了添加链接的内容\" data-itemshowtype=\"0\" tab=\"innerlink\" data-linktype=\"2\" hasload=\"1\" style=\"-webkit-tap-highlight-color: rgba(0, 0, 0, 0);cursor: pointer;letter-spacing: 0.54px;\"></a><a target=\"_blank\" href=\"http://mp.weixin.qq.com/s?__biz=MzIyNDA2NTI4Mg==&amp;mid=2655453673&amp;idx=1&amp;sn=3bba7798293202e94c8db6d644016fba&amp;chksm=f3a70384c4d08a921c99a8e424dc56e1cb408dcc359103ebc617d10d6e6391fcf6ec43a0ad1e&amp;scene=21#wechat_redirect\" textvalue=\"你已选中了添加链接的内容\" data-itemshowtype=\"0\" tab=\"innerlink\" data-linktype=\"2\" hasload=\"1\" style=\"font-family: -apple-system-font, BlinkMacSystemFont, \" helvetica neue sc sans gb yahei ui arial sans-serif center normal rgba pointer></a><a target=\"_blank\" href=\"http://mp.weixin.qq.com/s?__biz=MzIyNDA2NTI4Mg==&amp;mid=2655452343&amp;idx=1&amp;sn=140d8c102f7e73949b26cbb4bd3681b4&amp;chksm=f3a6fedac4d177cc3aba99b87c5876a30fb93d7a7fa4de66c9c97b7f4838c020735ae6c2ccbd&amp;scene=21#wechat_redirect\" textvalue=\"你已选中了添加链接的内容\" data-itemshowtype=\"0\" tab=\"innerlink\" data-linktype=\"1\" hasload=\"1\" style=\"-webkit-tap-highlight-color: rgba(0, 0, 0, 0);cursor: pointer;font-family: -apple-system-font, BlinkMacSystemFont, \" helvetica neue sc sans gb yahei ui arial sans-serif center normal rgb><span class=\"js_jump_icon h5_image_link\" data-positionback=\"static\" style=\"line-height: 0;top: auto;left: auto;right: auto;bottom: auto;\"><img class=\"rich_pages\" data-cropselx1=\"0\" data-cropselx2=\"517\" data-cropsely1=\"0\" data-cropsely2=\"130\" data-ratio=\"0.25239234449760767\" data-s=\"300,640\" data-type=\"jpeg\" data-w=\"836\" style=\"border-width: 0px; border-style: initial; border-color: initial; border-radius: 12px; left: auto; top: auto; right: auto; bottom: auto; box-sizing: border-box !important; visibility: visible !important; width: 517px !important; max-width: 600px\" src=\"http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_jpg/LHibUTtMHPRMXUH98sicPZVg3iaJPzibJZCwlRe8riaglJiaRu6IIG17qzoN9AQ0xPuqExHibriaveLtqDbuSp8X4gcc7Q/640?wx_fmt=jpeg\"></span></a></section><p style=\"margin-right: 16px;margin-left: 16px;font-family: -apple-system-font, BlinkMacSystemFont, \" helvetica neue sc sans gb yahei ui arial sans-serif normal right rgb><br></p><section data-role=\"paragraph\" style=\"font-family: -apple-system-font, BlinkMacSystemFont, \" helvetica neue sc sans gb yahei ui arial sans-serif normal rgb><section label=\"Powered by 135editor.com\" data-role=\"outer\"><section data-role=\"paragraph\"><section label=\"Powered by 135editor.com\" data-role=\"outer\"><section label=\"Powered by 135editor.com\" data-role=\"outer\"><section data-id=\"95265\" data-tools=\"135编辑器\"><section data-width=\"100%\" style=\"width: 677px;text-align: center;\"><section style=\"background-position: center bottom;background-image: url(\" https: repeat-x inline-block><section data-brushtype=\"text\" style=\"padding-right: 12px;padding-bottom: 5px;padding-left: 12px;letter-spacing: 1.5px;font-size: 14px;\">END</section></section></section></section></section></section><p style=\"margin-top: 5px;text-align: center;line-height: 1.75em;letter-spacing: 1.5px;\"><br></p></section></section></section><section data-role=\"paragraph\" style=\"font-family: -apple-system-font, BlinkMacSystemFont, \" helvetica neue sc sans gb yahei ui arial sans-serif normal rgb><section style=\"margin-right: 16px;margin-left: 16px;text-align: center;min-height: 1em;\"><img class=\"rich_pages __bg_gif\" data-cropselx1=\"0\" data-cropselx2=\"546\" data-cropsely1=\"0\" data-cropsely2=\"231\" data-ratio=\"0.42566510172143973\" data-s=\"300,640\" data-type=\"gif\" data-w=\"639\" style=\"box-shadow: rgb(170, 170, 170) 0px 0px 14px 0px; box-sizing: border-box !important; visibility: visible !important; width: 546px !important; max-width: 600px\" src=\"http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_gif/LHibUTtMHPRM871k4diaCHnjTxWsaC0HGzZasyqmClIDyvbtm490myxgZ5uRf9RrksOo1rCnC1mLRtvHsAQA6aRw/640?wx_fmt=gif\"></section></section>\n                </div>\n\n    \n        <br>\n        <div id=\"js_toobar3\" class=\"rich_media_tool\">\n            <a target=\"_blank\" href=\"http://www.zhishifenzi.com/\" id=\"js_view_source\" class=\"media_tool_meta meta_primary\">阅读原文</a>\n        </div>\n    \n    <br>\n\n    \n        <a target=\"_blank\" href=\"http://mp.weixin.qq.com/s?__biz=MzIyNDA2NTI4Mg==&amp;mid=2655455316&amp;idx=1&amp;sn=017d10df0d39c6e2c41cb1bd39ece943&amp;chksm=f3a70a39c4d0832f105261c1c51120023e08ac46eda2ce7d54e950982b8c3f13eda076db8eb4&amp;scene=0#rd\" style=\"color: blue\" class=\"media_tool_meta meta_primary\">原文</a>\n        <br>\n    \n\n    \n\n    <img alt=\"\" width=\"1px\" height=\"1px\" class=\"\" style=\"width:1px;height:1px;display:none\" src=\"http://www.jintiankansha.me/rss_static/30650/b4mtMzzn9p\"></div></div>","descriptionType":"html","publishedDate":"Mon, 19 Oct 2020 00:20:00 +0000","feedId":1531,"bgimg":"http://img.100weidu.com/mmbiz_jpg/LHibUTtMHPROeP328PJfB3Whv866whYyR2Gj9FXbN65R4k0QibULCBNUI2ZnpeCicz47gbXQvicprBE7OPnvNGrTJw?imageView2/1/w/600","linkMd5":"9cae5947d34d8289155b69d14e849dad","bgimgJsdelivr":"https://cdn.jsdelivr.net/gh/myreaderx2/cdn44@2020_3/2020/10/20/02-10-13-001_537810d7ec471c27.webp","destWidth":600,"destHeight":540,"sourceBytes":25031,"destBytes":15856,"author":"","articleImgCdnMap":{"http://img.100weidu.com/mmbiz_jpg/LHibUTtMHPROeP328PJfB3Whv866whYyR2Gj9FXbN65R4k0QibULCBNUI2ZnpeCicz47gbXQvicprBE7OPnvNGrTJw?imageView2/1/w/600":"https://cdn.jsdelivr.net/gh/myreaderx8/cdn63@2020_2/2020/10/20/02-10-11-716_537810d7ec471c27.webp","http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_png/LHibUTtMHPROeP328PJfB3Whv866whYyRLskFHqs4s9QSoKpNmGCTibuUd4dmFuGicprhMEicicbSg2BpmjazhjkalQ/640?wx_fmt=png":null,"http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_png/LHibUTtMHPRM5Ud8d7rOrOJZmevzXI7jkWPQBKNS1T4U2CFbBsLHLZqKukUV52RiaDRiaVKuLnOshZeeEDWuDse3w/640?wx_fmt=png":"https://cdn.jsdelivr.net/gh/myreaderx1/cdn84@2020_1/2020/10/20/02-10-11-637_8ae0aba223f05c44.webp","http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_gif/LHibUTtMHPRM5Ud8d7rOrOJZmevzXI7jkbtS6NgcCtYfhOYnbRDqWPyibaelA4pIB0lvdg99hJfsmdibm2Eibg6dDQ/640?wx_fmt=gif":"https://cdn.jsdelivr.net/gh/myreaderx3/cdn75@2020_5/2020/10/20/02-10-17-969_5172cd85a08ee73b.webp","http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_gif/lBLXrFcccXFwZwrMI7x3Idm0WicwB4ibviaNqA7dU3PEVQZrafvvMVQV4muo1DuHlPLtLIAwFbMWic5VGyn7G1vIuQ/640?wx_fmt=gif":"https://cdn.jsdelivr.net/gh/myreaderx5oss/cdn72@2020_6/2020/10/20/02-10-17-266_bf9d412e67e73107.webp","http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_jpg/LHibUTtMHPROeP328PJfB3Whv866whYyRZeZm1ibBIlJCS7PDbZHtjSuA5ZNtZlGLE4B7XocR1GzDf7HXxHQl7UQ/640?wx_fmt=jpeg":"https://cdn.jsdelivr.net/gh/myreaderx15/cdn78@2020_2/2020/10/20/02-10-16-362_cef8bbcd1daaa81e.webp","http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_jpg/LHibUTtMHPRMDggld9qfmopYm6Ss6b1VH3uXvwVQaZ2TQZO7RSa42BTTxzGXrs4xricISG9qH0TZZpXS4xWgtiagQ/640?wx_fmt=jpeg":"https://cdn.jsdelivr.net/gh/myreaderx32/cdn48@2020_1/2020/10/20/02-10-24-891_965b05a7eb94d125.webp","http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_jpg/LHibUTtMHPRMXUH98sicPZVg3iaJPzibJZCwlRe8riaglJiaRu6IIG17qzoN9AQ0xPuqExHibriaveLtqDbuSp8X4gcc7Q/640?wx_fmt=jpeg":"https://cdn.jsdelivr.net/gh/myreaderx30/cdn68@2020_2/2020/10/20/02-10-29-796_378615b366c13cb0.webp","http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_gif/LHibUTtMHPRM871k4diaCHnjTxWsaC0HGzZasyqmClIDyvbtm490myxgZ5uRf9RrksOo1rCnC1mLRtvHsAQA6aRw/640?wx_fmt=gif":"https://cdn.jsdelivr.net/gh/myreaderx13/cdn59@2020_2/2020/10/20/02-10-21-906_53230ba3aabf500c.webp","http://www.jintiankansha.me/rss_static/30650/b4mtMzzn9p":null},"publishedOrCreatedDate":1603159689702}],"record":{"createdTime":"2020-10-20 10:08:09","updatedTime":"2020-10-20 10:08:09","feedId":1531,"fetchDate":"Tue, 20 Oct 2020 02:08:09 +0000","fetchMs":200,"handleMs":33,"totalMs":242703,"newArticles":0,"totalArticles":5,"status":1,"type":0,"ip":"cf9af02d3e458080dedc42d3da41bbb4","hostName":"us-011*","requestId":"74a5911a6f35482ba3d261a8a078e291_1531","contentType":"application/rss+xml","totalBytes":233228,"bgimgsTotal":1,"bgimgsGithubTotal":1,"articlesImgsTotal":10,"articlesImgsGithubTotal":8,"successGithubMap":{"myreaderx8":1,"myreaderx15":1,"myreaderx32":1,"myreaderx3":1,"myreaderx2":1,"myreaderx1":1,"myreaderx13":1,"myreaderx30":1,"myreaderx5oss":1},"failGithubMap":{}},"feed":{"createdTime":"2020-08-24 21:31:30","updatedTime":"2020-09-01 09:48:48","id":1531,"name":"知识分子","url":"http://feedmaker.kindle4rss.com/feeds/The-Intellectual.weixin.xml","subscriber":null,"website":null,"icon":"http://www.sogou.com/images/logo/new/favicon.ico?v=4","icon_jsdelivr":"https://cdn.jsdelivr.net/gh/myreaderx65/cdn45@2020_1/2020/09/01/01-48-33-569_d24121c9beed1de6.ico","description":"《知识分子》是由饶毅、鲁白、谢宇三位学者创办的移动新媒体平台，致力于关注科学、人文、思想。我们将兼容并包，时刻为渴望知识、独立思考的人努力，共享人类知识、共析现代思想、共建智趣中国。欢迎关注。","weekly":null,"link":null},"noPictureArticleList":[{"createdTime":"2020-10-20 10:12:11","updatedTime":"2020-10-20 10:12:11","id":null,"feedId":1531,"linkMd5":"9cae5947d34d8289155b69d14e849dad"}],"tmpCommonImgCdnBytes":0,"tmpBodyImgCdnBytes":233228,"tmpBgImgCdnBytes":0,"extra4":{"start":1603159689262,"total":0,"statList":[{"spend":408,"msg":"获取xml内容"},{"spend":33,"msg":"解释文章"},{"spend":3641,"msg":"上传封面图到cdn"},{"spend":0,"msg":"修正封面图上传失败重新上传"},{"spend":121725,"msg":"正文链接上传到cdn"}]},"extra5":10,"extra6":9,"extra7ImgCdnFailResultVector":[null,null,{"code":1,"isDone":false,"source":"http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_gif/LHibUTtMHPRM871k4diaCHnjTxWsaC0HGzZasyqmClIDyvbtm490myxgZ5uRf9RrksOo1rCnC1mLRtvHsAQA6aRw/640?wx_fmt=gif","sourceStatusCode":403,"sourceBytes":0,"destBytes":0,"feedId":1531,"totalSpendMs":1051,"convertSpendMs":0,"createdTime":"2020-10-20 10:10:10","host":"europe65*","referer":"http://weixin.sogou.com/weixin?type=2&query=%E7%9F%A5%E8%AF%86%E5%88%86%E5%AD%90+%E9%AB%98%E9%BE%84%E3%80%81%E5%9F%BA%E7%A1%80%E7%97%85%E5%A4%96%E7%9A%84%E9%87%8D%E7%97%87%E5%8E%9F%E5%9B%A0%EF%BC%9A%E5%B9%B2%E6%89%B0%E7%B4%A0%E7%BC%BA%E5%A4%B1%E6%88%96%E8%87%B413%25%E7%9A%84%E6%96%B0%E5%86%A0%E9%87%8D%E7%97%87","linkMd5ListStr":"9cae5947d34d8289155b69d14e849dad","extra22GetBytesInfo":"2、Referer字段 ： http://weixin.sogou.com/weixin?type=2&query=%E7%9F%A5%E8%AF%86%E5%88%86%E5%AD%90+%E9%AB%98%E9%BE%84%E3%80%81%E5%9F%BA%E7%A1%80%E7%97%85%E5%A4%96%E7%9A%84%E9%87%8D%E7%97%87%E5%8E%9F%E5%9B%A0%EF%BC%9A%E5%B9%B2%E6%89%B0%E7%B4%A0%E7%BC%BA%E5%A4%B1%E6%88%96%E8%87%B413%25%E7%9A%84%E6%96%B0%E5%86%A0%E9%87%8D%E7%97%87","extra23historyStatusCode":[403,403],"sourceSize":"0","destSize":"0"},{"code":1,"isDone":false,"source":"http://www.jintiankansha.me/rss_static/30650/b4mtMzzn9p","sourceStatusCode":405,"sourceBytes":0,"destBytes":0,"feedId":1531,"totalSpendMs":2321,"convertSpendMs":0,"createdTime":"2020-10-20 10:10:10","host":"us-002*","referer":"http://weixin.sogou.com/weixin?type=2&query=%E7%9F%A5%E8%AF%86%E5%88%86%E5%AD%90+%E9%AB%98%E9%BE%84%E3%80%81%E5%9F%BA%E7%A1%80%E7%97%85%E5%A4%96%E7%9A%84%E9%87%8D%E7%97%87%E5%8E%9F%E5%9B%A0%EF%BC%9A%E5%B9%B2%E6%89%B0%E7%B4%A0%E7%BC%BA%E5%A4%B1%E6%88%96%E8%87%B413%25%E7%9A%84%E6%96%B0%E5%86%A0%E9%87%8D%E7%97%87","linkMd5ListStr":"9cae5947d34d8289155b69d14e849dad","extra22GetBytesInfo":"1、没有Referer字段","extra23historyStatusCode":[405],"sourceSize":"0","destSize":"0"},{"code":1,"isDone":false,"source":"http://www.jintiankansha.me/rss_static/30650/b4mtMzzn9p","sourceStatusCode":405,"sourceBytes":0,"destBytes":0,"feedId":1531,"totalSpendMs":461,"convertSpendMs":0,"createdTime":"2020-10-20 10:10:12","host":"us-53*","referer":"http://weixin.sogou.com/weixin?type=2&query=%E7%9F%A5%E8%AF%86%E5%88%86%E5%AD%90+%E9%AB%98%E9%BE%84%E3%80%81%E5%9F%BA%E7%A1%80%E7%97%85%E5%A4%96%E7%9A%84%E9%87%8D%E7%97%87%E5%8E%9F%E5%9B%A0%EF%BC%9A%E5%B9%B2%E6%89%B0%E7%B4%A0%E7%BC%BA%E5%A4%B1%E6%88%96%E8%87%B413%25%E7%9A%84%E6%96%B0%E5%86%A0%E9%87%8D%E7%97%87","linkMd5ListStr":"9cae5947d34d8289155b69d14e849dad","extra22GetBytesInfo":"1、没有Referer字段","extra23historyStatusCode":[405],"sourceSize":"0","destSize":"0"},null,null],"extra10_invalidATagHrefValue":{},"extra111_proxyServerAndStatMap":{"http://us-038.herokuapp.com/":{"failCount":0,"successCount":1,"resultList":[200]},"http://us-53.herokuapp.com/":{"failCount":1,"successCount":1,"resultList":[200,405]},"http://europe69.herokuapp.com/":{"failCount":1,"successCount":1,"resultList":[200,null]},"http://europe65.herokuapp.com/":{"failCount":1,"successCount":0,"resultList":[403]},"http://europe68.herokuapp.com/":{"failCount":0,"successCount":1,"resultList":[200]},"http://us-031.herokuapp.com/":{"failCount":0,"successCount":1,"resultList":[200]},"http://us-002.herokuapp.com/":{"failCount":1,"successCount":0,"resultList":[405]},"http://us-019.herokuapp.com/":{"failCount":0,"successCount":1,"resultList":[200]},"http://europe-57.herokuapp.com/":{"failCount":0,"successCount":1,"resultList":[200]},"http://us-015.herokuapp.com/":{"failCount":1,"successCount":0,"resultList":[null]},"http://us-027.herokuapp.com/":{"failCount":0,"successCount":1,"resultList":[200]}},"extra12ImgCdnSuccessResultVector":[{"code":1,"isDone":false,"source":"http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_png/LHibUTtMHPRM5Ud8d7rOrOJZmevzXI7jkWPQBKNS1T4U2CFbBsLHLZqKukUV52RiaDRiaVKuLnOshZeeEDWuDse3w/640?wx_fmt=png","sourceStatusCode":200,"destWidth":92,"destHeight":90,"fixedGithubDest":"https://cdn.jsdelivr.net/gh/myreaderx1/cdn84@2020_1/2020/10/20/02-10-11-637_8ae0aba223f05c44.webp","sourceBytes":4625,"destBytes":2870,"targetWebpQuality":75,"feedId":1531,"totalSpendMs":2128,"convertSpendMs":6,"createdTime":"2020-10-20 10:10:10","host":"europe-57*","referer":"http://weixin.sogou.com/weixin?type=2&query=%E7%9F%A5%E8%AF%86%E5%88%86%E5%AD%90+%E9%AB%98%E9%BE%84%E3%80%81%E5%9F%BA%E7%A1%80%E7%97%85%E5%A4%96%E7%9A%84%E9%87%8D%E7%97%87%E5%8E%9F%E5%9B%A0%EF%BC%9A%E5%B9%B2%E6%89%B0%E7%B4%A0%E7%BC%BA%E5%A4%B1%E6%88%96%E8%87%B413%25%E7%9A%84%E6%96%B0%E5%86%A0%E9%87%8D%E7%97%87","linkMd5ListStr":"9cae5947d34d8289155b69d14e849dad","githubUser":"myreaderx1","githubHttpCode":201,"extra22GetBytesInfo":"1、没有Referer字段","extra23historyStatusCode":[200],"sourceSize":"4.5 KB","destSize":"2.8 KB","compressRate":"62.1%"},{"code":1,"isDone":false,"source":"http://img.100weidu.com/mmbiz_jpg/LHibUTtMHPROeP328PJfB3Whv866whYyR2Gj9FXbN65R4k0QibULCBNUI2ZnpeCicz47gbXQvicprBE7OPnvNGrTJw?imageView2/1/w/600","sourceStatusCode":200,"destWidth":600,"destHeight":540,"fixedGithubDest":"https://cdn.jsdelivr.net/gh/myreaderx8/cdn63@2020_2/2020/10/20/02-10-11-716_537810d7ec471c27.webp","sourceBytes":25031,"destBytes":15856,"targetWebpQuality":75,"feedId":1531,"totalSpendMs":2290,"convertSpendMs":37,"createdTime":"2020-10-20 10:10:10","host":"us-53*","referer":"http://weixin.sogou.com/weixin?type=2&query=%E7%9F%A5%E8%AF%86%E5%88%86%E5%AD%90+%E9%AB%98%E9%BE%84%E3%80%81%E5%9F%BA%E7%A1%80%E7%97%85%E5%A4%96%E7%9A%84%E9%87%8D%E7%97%87%E5%8E%9F%E5%9B%A0%EF%BC%9A%E5%B9%B2%E6%89%B0%E7%B4%A0%E7%BC%BA%E5%A4%B1%E6%88%96%E8%87%B413%25%E7%9A%84%E6%96%B0%E5%86%A0%E9%87%8D%E7%97%87","linkMd5ListStr":"9cae5947d34d8289155b69d14e849dad,9cae5947d34d8289155b69d14e849dad","githubUser":"myreaderx8","githubHttpCode":201,"extra22GetBytesInfo":"1、没有Referer字段","extra23historyStatusCode":[200],"sourceSize":"24.4 KB","destSize":"15.5 KB","compressRate":"63.3%"},{"code":1,"isDone":false,"source":"http://img.100weidu.com/mmbiz_jpg/LHibUTtMHPROeP328PJfB3Whv866whYyR2Gj9FXbN65R4k0QibULCBNUI2ZnpeCicz47gbXQvicprBE7OPnvNGrTJw?imageView2/1/w/600","sourceStatusCode":200,"destWidth":600,"destHeight":540,"fixedGithubDest":"https://cdn.jsdelivr.net/gh/myreaderx2/cdn44@2020_3/2020/10/20/02-10-13-001_537810d7ec471c27.webp","sourceBytes":25031,"destBytes":15856,"targetWebpQuality":75,"feedId":1531,"totalSpendMs":3622,"convertSpendMs":24,"createdTime":"2020-10-20 10:10:10","host":"us-039*","referer":"http://weixin.sogou.com/weixin?type=2&query=%E7%9F%A5%E8%AF%86%E5%88%86%E5%AD%90+%E9%AB%98%E9%BE%84%E3%80%81%E5%9F%BA%E7%A1%80%E7%97%85%E5%A4%96%E7%9A%84%E9%87%8D%E7%97%87%E5%8E%9F%E5%9B%A0%EF%BC%9A%E5%B9%B2%E6%89%B0%E7%B4%A0%E7%BC%BA%E5%A4%B1%E6%88%96%E8%87%B413%25%E7%9A%84%E6%96%B0%E5%86%A0%E9%87%8D%E7%97%87","linkMd5ListStr":"9cae5947d34d8289155b69d14e849dad,9cae5947d34d8289155b69d14e849dad","githubUser":"myreaderx2","githubHttpCode":201,"extra22GetBytesInfo":"1、没有Referer字段","extra23historyStatusCode":[200],"sourceSize":"24.4 KB","destSize":"15.5 KB","compressRate":"63.3%"},{"code":1,"isDone":false,"source":"http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_jpg/LHibUTtMHPROeP328PJfB3Whv866whYyRZeZm1ibBIlJCS7PDbZHtjSuA5ZNtZlGLE4B7XocR1GzDf7HXxHQl7UQ/640?wx_fmt=jpeg","sourceStatusCode":200,"destWidth":960,"destHeight":242,"fixedGithubDest":"https://cdn.jsdelivr.net/gh/myreaderx15/cdn78@2020_2/2020/10/20/02-10-16-362_cef8bbcd1daaa81e.webp","sourceBytes":27075,"destBytes":21842,"targetWebpQuality":75,"feedId":1531,"totalSpendMs":7023,"convertSpendMs":10,"createdTime":"2020-10-20 10:10:10","host":"europe69*","referer":"http://weixin.sogou.com/weixin?type=2&query=%E7%9F%A5%E8%AF%86%E5%88%86%E5%AD%90+%E9%AB%98%E9%BE%84%E3%80%81%E5%9F%BA%E7%A1%80%E7%97%85%E5%A4%96%E7%9A%84%E9%87%8D%E7%97%87%E5%8E%9F%E5%9B%A0%EF%BC%9A%E5%B9%B2%E6%89%B0%E7%B4%A0%E7%BC%BA%E5%A4%B1%E6%88%96%E8%87%B413%25%E7%9A%84%E6%96%B0%E5%86%A0%E9%87%8D%E7%97%87","linkMd5ListStr":"9cae5947d34d8289155b69d14e849dad","githubUser":"myreaderx15","githubHttpCode":201,"extra22GetBytesInfo":"1、没有Referer字段","extra23historyStatusCode":[200],"sourceSize":"26.4 KB","destSize":"21.3 KB","compressRate":"80.7%"},{"code":1,"isDone":false,"source":"http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_gif/lBLXrFcccXFwZwrMI7x3Idm0WicwB4ibviaNqA7dU3PEVQZrafvvMVQV4muo1DuHlPLtLIAwFbMWic5VGyn7G1vIuQ/640?wx_fmt=gif","sourceStatusCode":200,"destWidth":462,"destHeight":40,"fixedGithubDest":"https://cdn.jsdelivr.net/gh/myreaderx5oss/cdn72@2020_6/2020/10/20/02-10-17-266_bf9d412e67e73107.webp","sourceBytes":68255,"destBytes":82152,"targetWebpQuality":75,"feedId":1531,"totalSpendMs":8144,"convertSpendMs":197,"createdTime":"2020-10-20 10:10:10","host":"us-019*","referer":"http://weixin.sogou.com/weixin?type=2&query=%E7%9F%A5%E8%AF%86%E5%88%86%E5%AD%90+%E9%AB%98%E9%BE%84%E3%80%81%E5%9F%BA%E7%A1%80%E7%97%85%E5%A4%96%E7%9A%84%E9%87%8D%E7%97%87%E5%8E%9F%E5%9B%A0%EF%BC%9A%E5%B9%B2%E6%89%B0%E7%B4%A0%E7%BC%BA%E5%A4%B1%E6%88%96%E8%87%B413%25%E7%9A%84%E6%96%B0%E5%86%A0%E9%87%8D%E7%97%87","linkMd5ListStr":"9cae5947d34d8289155b69d14e849dad","githubUser":"myreaderx5oss","githubHttpCode":201,"extra22GetBytesInfo":"1、没有Referer字段","extra23historyStatusCode":[200],"sourceSize":"66.7 KB","destSize":"80.2 KB","compressRate":"120.4%"},{"code":1,"isDone":false,"source":"http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_gif/LHibUTtMHPRM5Ud8d7rOrOJZmevzXI7jkbtS6NgcCtYfhOYnbRDqWPyibaelA4pIB0lvdg99hJfsmdibm2Eibg6dDQ/640?wx_fmt=gif","sourceStatusCode":200,"destWidth":200,"destHeight":200,"fixedGithubDest":"https://cdn.jsdelivr.net/gh/myreaderx3/cdn75@2020_5/2020/10/20/02-10-17-969_5172cd85a08ee73b.webp","sourceBytes":14253,"destBytes":22552,"targetWebpQuality":75,"feedId":1531,"totalSpendMs":8761,"convertSpendMs":48,"createdTime":"2020-10-20 10:10:10","host":"europe68*","referer":"http://weixin.sogou.com/weixin?type=2&query=%E7%9F%A5%E8%AF%86%E5%88%86%E5%AD%90+%E9%AB%98%E9%BE%84%E3%80%81%E5%9F%BA%E7%A1%80%E7%97%85%E5%A4%96%E7%9A%84%E9%87%8D%E7%97%87%E5%8E%9F%E5%9B%A0%EF%BC%9A%E5%B9%B2%E6%89%B0%E7%B4%A0%E7%BC%BA%E5%A4%B1%E6%88%96%E8%87%B413%25%E7%9A%84%E6%96%B0%E5%86%A0%E9%87%8D%E7%97%87","linkMd5ListStr":"9cae5947d34d8289155b69d14e849dad","githubUser":"myreaderx3","githubHttpCode":201,"extra22GetBytesInfo":"1、没有Referer字段","extra23historyStatusCode":[200],"sourceSize":"13.9 KB","destSize":"22 KB","compressRate":"158.2%"},{"code":1,"isDone":false,"source":"http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_gif/LHibUTtMHPRM871k4diaCHnjTxWsaC0HGzZasyqmClIDyvbtm490myxgZ5uRf9RrksOo1rCnC1mLRtvHsAQA6aRw/640?wx_fmt=gif","sourceStatusCode":200,"destWidth":639,"destHeight":272,"fixedGithubDest":"https://cdn.jsdelivr.net/gh/myreaderx13/cdn59@2020_2/2020/10/20/02-10-21-906_53230ba3aabf500c.webp","sourceBytes":26623,"destBytes":12888,"targetWebpQuality":75,"feedId":1531,"totalSpendMs":11321,"convertSpendMs":130,"createdTime":"2020-10-20 10:10:11","host":"us-038*","referer":"http://weixin.sogou.com/weixin?type=2&query=%E7%9F%A5%E8%AF%86%E5%88%86%E5%AD%90+%E9%AB%98%E9%BE%84%E3%80%81%E5%9F%BA%E7%A1%80%E7%97%85%E5%A4%96%E7%9A%84%E9%87%8D%E7%97%87%E5%8E%9F%E5%9B%A0%EF%BC%9A%E5%B9%B2%E6%89%B0%E7%B4%A0%E7%BC%BA%E5%A4%B1%E6%88%96%E8%87%B413%25%E7%9A%84%E6%96%B0%E5%86%A0%E9%87%8D%E7%97%87","linkMd5ListStr":"9cae5947d34d8289155b69d14e849dad","githubUser":"myreaderx13","githubHttpCode":201,"extra22GetBytesInfo":"1、没有Referer字段","extra23historyStatusCode":[200],"sourceSize":"26 KB","destSize":"12.6 KB","compressRate":"48.4%"},{"code":1,"isDone":false,"source":"http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_jpg/LHibUTtMHPRMDggld9qfmopYm6Ss6b1VH3uXvwVQaZ2TQZO7RSa42BTTxzGXrs4xricISG9qH0TZZpXS4xWgtiagQ/640?wx_fmt=jpeg","sourceStatusCode":200,"destWidth":1000,"destHeight":252,"fixedGithubDest":"https://cdn.jsdelivr.net/gh/myreaderx32/cdn48@2020_1/2020/10/20/02-10-24-891_965b05a7eb94d125.webp","sourceBytes":62042,"destBytes":50026,"targetWebpQuality":75,"feedId":1531,"totalSpendMs":15529,"convertSpendMs":28,"createdTime":"2020-10-20 10:10:10","host":"us-027*","referer":"http://weixin.sogou.com/weixin?type=2&query=%E7%9F%A5%E8%AF%86%E5%88%86%E5%AD%90+%E9%AB%98%E9%BE%84%E3%80%81%E5%9F%BA%E7%A1%80%E7%97%85%E5%A4%96%E7%9A%84%E9%87%8D%E7%97%87%E5%8E%9F%E5%9B%A0%EF%BC%9A%E5%B9%B2%E6%89%B0%E7%B4%A0%E7%BC%BA%E5%A4%B1%E6%88%96%E8%87%B413%25%E7%9A%84%E6%96%B0%E5%86%A0%E9%87%8D%E7%97%87","linkMd5ListStr":"9cae5947d34d8289155b69d14e849dad","githubUser":"myreaderx32","githubHttpCode":201,"extra22GetBytesInfo":"1、没有Referer字段","extra23historyStatusCode":[200],"sourceSize":"60.6 KB","destSize":"48.9 KB","compressRate":"80.6%"},{"code":1,"isDone":false,"source":"http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_jpg/LHibUTtMHPRMXUH98sicPZVg3iaJPzibJZCwlRe8riaglJiaRu6IIG17qzoN9AQ0xPuqExHibriaveLtqDbuSp8X4gcc7Q/640?wx_fmt=jpeg","sourceStatusCode":200,"destWidth":836,"destHeight":211,"fixedGithubDest":"https://cdn.jsdelivr.net/gh/myreaderx30/cdn68@2020_2/2020/10/20/02-10-29-796_378615b366c13cb0.webp","sourceBytes":30302,"destBytes":25042,"targetWebpQuality":75,"feedId":1531,"totalSpendMs":20487,"convertSpendMs":9,"createdTime":"2020-10-20 10:10:10","host":"us-031*","referer":"http://weixin.sogou.com/weixin?type=2&query=%E7%9F%A5%E8%AF%86%E5%88%86%E5%AD%90+%E9%AB%98%E9%BE%84%E3%80%81%E5%9F%BA%E7%A1%80%E7%97%85%E5%A4%96%E7%9A%84%E9%87%8D%E7%97%87%E5%8E%9F%E5%9B%A0%EF%BC%9A%E5%B9%B2%E6%89%B0%E7%B4%A0%E7%BC%BA%E5%A4%B1%E6%88%96%E8%87%B413%25%E7%9A%84%E6%96%B0%E5%86%A0%E9%87%8D%E7%97%87","linkMd5ListStr":"9cae5947d34d8289155b69d14e849dad","githubUser":"myreaderx30","githubHttpCode":201,"extra22GetBytesInfo":"1、没有Referer字段","extra23historyStatusCode":[200],"sourceSize":"29.6 KB","destSize":"24.5 KB","compressRate":"82.6%"}],"successGithubMap":{"myreaderx8":1,"myreaderx15":1,"myreaderx32":1,"myreaderx3":1,"myreaderx2":1,"myreaderx1":1,"myreaderx13":1,"myreaderx30":1,"myreaderx5oss":1},"failGithubMap":{}}